Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Mar 22;19(6):e867–e876. doi: 10.1200/OP.22.00811

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by American Society of Clinical Oncology

Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/

PMC Copyright notice

FIG 1. — Physician considerations when treating cHL. (A) Question: What are the most important considerations for you when treating cHL? Please rank up to five. (B) Question: When treating cHL, how much do you consider the following guidelines? Response on the basis of the percentage of physicians selecting either four or five on the 5-point scale shown. cHL, classic Hodgkin lymphoma; ESMO, European Society for Medical Oncology; ILROG, International Lymphoma Radiation Oncology Group; KOLs, key opinion leaders; NCCN, National Comprehensive Cancer Network.